T1	p 77 108	treated hypertensive patients .
T2	p 275 339	hypertensive patients receiving drug treatment , but data on the
T3	p 348 350	of
T4	p 360 367	aspirin
T5	p 439 442	low
T6	p 545 605	hypertensives on chronic , stable antihypertensive therapy .
T7	p 785 1058	people with one or more cardiovascular risk factors . Fifteen Italian hypertension units studied 142 hypertensive patients ( 76 men , 66 women ; mean age 59 +/- 5.9 years ) treated with different antihypertensive drugs : 71 patients were randomized to aspirin and 71 served
T8	p 1062 1085	controls . All patients
T9	p 1160 1189	24-h ambulatory BP monitoring
T10	p 1208 1215	after 3
T11	p 1223 1245	of aspirin treatment .
T12	p 1940 1971	hypertensives under treatment .
T13	i 17 33	low-dose aspirin
T14	i 109 122	Collaborative
T15	i 136 162	Primary Prevention Project
T16	i 165 173	PPP ) --
T17	i 193 230	. Nonsteroidal antiinflammatory drugs
T18	i 360 367	aspirin
T19	i 449 474	of aspirin ( 100 mg/day )
T20	i 761 781	aspirin or vitamin E
T21	i 1037 1058	aspirin and 71 served
T22	i 1062 1072	controls .
T23	i 1098 1107	clinic BP
T24	i 1124 1245	an automatic sphygmomanometer and a 24-h ambulatory BP monitoring , at baseline and after 3 months of aspirin treatment .
T25	i 1414 1421	aspirin
T26	i 1681 1688	aspirin
T27	i 1769 1779	inhibitors
T28	i 1784 1791	calcium
T29	i 1915 1922	aspirin
T30	o 37 73	clinic and ambulatory blood pressure
T31	o 242 263	blood pressure ( BP )
T32	o 478 541	clinic and ambulatory systolic ( SBP ) and diastolic ( DBP ) BP
T33	o 1282 1303	in clinic SBP and DBP
T34	o 1373 1395	Ambulatory SBP and DBP
T35	o 1926 1936	BP control